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Selenoproteins are an elite group of proteins containing a rare
amino acid, selenocysteine (Sec), encoded by the codon, UGA. In
eukaryotes, incorporation of Sec requires a Sec insertion sequence
(SECIS) element, a stem–loop structure located in the 3-untrans-
lated regions of selenoprotein mRNAs. Here we report identifica-
tion of a noncanonical form of SECIS element in Toxoplasma gondii
and Neospora canine, single-celled apicomplexan parasites of hu-
mans and domestic animals. This SECIS has a GGGA sequence in the
SBP2-binding site in place of AUGA previously considered invari-
ant. Using a combination of computational and molecular tech-
niques, we show that Toxoplasma and Neospora possess both
canonical and noncanonical SECIS elements. The GGGA-type SECIS
element supported Sec insertion in mammalian HEK 293 and NIH
3T3 cells and did so more efficiently than the natural mammalian
SECIS elements tested. In addition, mammalian type I and type II
SECIS elements mutated into the GGGA forms were functional but
manifested decreased Sec insertion efficiency. We carried out
computational searches for both AUGA and GGGA forms of SECIS
elements in Toxoplasma and detected five selenoprotein genes,
including one coding for a previously undescribed selenoprotein,
designated SelQ, and two containing the GGGA form of the SECIS
element. In contrast, the GGGA-type SECIS elements were not
detected in mammals and nematodes. As a practical outcome of the
study, we developed pSelExpress1, a vector for convenient expres-
sion of selenoproteins in mammalian cells. It contains an SBP2 gene
and the most efficient tested SECIS element: an AUGA mutant of
the GGGA-type Toxoplasma SelT structure.
genome  RNA structure  selenocysteine  selenoprotein
Selenocysteine (Sec)-containing proteins (selenoproteins) arerare but widely distributed in all domains of life (1), including
bacteria (2, 3), archaea (4), and eukaryotes (5–7). The human
genome possesses 25 genes encoding such proteins (7). The class
of selenoproteins is defined by the occurrence of Sec, the 21st
amino acid encoded by the UGA codon. Selenoproteins use the
high reactivity of Sec, which is located in catalytic centers and
serves redox function analogous to the functions of redox-active
Cys residues (8). In addition to the UGA codon, a cis-acting
element is present within selenoprotein genes, which is also
essential for recognition of UGA as the Sec codon. This element
is a stem–loop structure, known as the Sec insertion sequence
(SECIS) located in coding regions of bacterial and in 3-UTRs
of archaeal and eukaryotic selenoprotein genes (9, 10).
The principal features of the eukaryotic SECIS element include
a segment containing four non-Watson–Crick base pairs
UGAN. . . . NGAN (designated the quartet or core), an unpaired
A preceding the quartet, and an unpaired AA or CC motif in the
apical loop or bulge that is separated from the quartet by 11–12
nucleotides (11–14). Although having low sequence conservation,
the secondary structure of eukaryotic SECIS elements is strictly
conserved and thermodynamically stable (15, 16). Based on these
observations, several algorithms have been developed and success-
fully applied in genomic searches to identify these stem–loop
structures, and thereby selenoprotein genes, in nucleotide sequence
databases (5, 7, 17–19).
It has been established that the quartet is involved in the
interaction with SECIS-binding protein 2 (SBP2) (20, 21), which, in
turn, is essential for the formation of a complexwith the Sec-specific
elongation factor, known as EFsec, and tRNA[Ser]Sec (22, 23). This
protein–RNA complex functions by inserting Sec in response to
UGAcodons (24).Recently, additional components of the complex
were reported, including the L30 protein that interacts with the
SECIS element in vitro and in vivo and competes with SBP2 for
SECIS binding (25). In addition, SECp43 and SLA have roles in
selenoprotein biosynthesis through interaction with tRNA[Ser]Sec
in a supramolecular complex (26, 27).
It has been found that the four consecutive non-Watson–Crick
base pairs are part of a recurrent motif, the kink-turn (K-turn), and
constitute the functional motif of the SECIS structure, which is
recognized by SBP2. It has been proposed that the invariant U in
the conserved AUGA sequence forms a non-Watson–Crick base
pair with another U in 5DI SECIS RNA (12, 28). Similarly, it is
thought this U may form a base pair with the corresponding
nucleotide independent of its identity. The analysis of crystal
structures of RNA–protein complexes suggested the residue at this
position binds in a pocket of RNA-binding proteins (29–31). It was
also proposed that the SECIS core is a K-turn-like motif, which
provides greater flexibility and allows switching between open and
closed kinked conformations. In turn, this feature triggers a major
conformational change in the SBP2-bound complex (25, 28).
In our study, we found that the U in the quartet, previously
considered an invariant residue, is not conserved in some apicom-
plexan selenoprotein genes. Instead, a previously undescribed form
of SECIS element was found that has a GGGA sequence in place
of the conserved AUGA sequence.We characterized this structure
in detail using a combination of computational and molecular
approaches.
Results and Discussion
Identification of a Noncanonical Form of Eukaryotic SECIS Element.A
search for Toxoplasma selenoprotein genes was carried out by
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homology analyses involving all known selenoproteins as queries.
This procedure identified homologs of four mammalian selenopro-
teins: SelW, SelK, SelS, and SelT [supporting information (SI) Figs.
6–9]. Their genes had predicted Sec residues encoded by UGA
codons. Analysis of the 3-UTRs in these selenoprotein genes
revealed the presence of canonical SECIS elements in SelK and
SelW genes (Fig. 1A). However, no suitable structure was found in
the SelT 3-UTR. The use of relaxed settings and the loose pattern
of SECISearch did not yield candidate SECIS structures in the
Toxoplasma SelT gene.
The lack of a standard SECIS element in the SelT gene suggested
the presence of a noncanonical structure. Manual analysis of the
SelT 3-UTR using MFOLD revealed a SECIS-like structure that
satisfied all SECIS element requirements with one notable excep-
tion: the SBP2-binding site (e.g., SECIS core or quartet) had a
GGGA sequence instead ofAUGA (Fig. 1A). TheU in theAUGA
sequence is considered invariant and is present in all known
eukaryotic SECIS elements. To examine whether the GGGA
sequence in the SECIS core represented a sequencing error, we
analyzed additional protozoan sequences. EST sequences of Neos-
pora caninum, another apicomplexan parasite, revealed a SelW
homolog containing a canonical SECIS element and a SelT ho-
molog containing a GGGA-type SECIS element (Fig. 1A). The
occurrence of the same noncanonical SECIS-like structure in two
different organisms was a strong indication that this structure is the
true SECIS element.
The New Type of SECIS Element Is Functional. We prepared the
constructs coding for GFP SelH fusion proteins, in which the
natural SelH SECIS element was replacedwithToxoplasma SelT or
SelS SECIS elements (Fig. 2A) and expressed these proteins in
mammalian HEK 293 (Fig. 2B) and NIH 3T3 (Fig. 2C) cells.
Expression of the fusion protein was predicted to result in an
40-kDa product (Fig. 2A). Indeed, metabolic labeling of the
transfected cells with 75Se revealed a 40-kDa band (lanes 1–8, Fig.
2 B Upper and C Upper). This band was not present in cells
transfected with the corresponding constructs lacking 3UTRs
(lanes 11, Fig. 2 B and C) or the constructs in which the Sec-
encoding codons were mutated to cysteine codons (lanes 12, Fig. 2
B and C). We also examined whether SBP2 could influence
expression levels of the expressed selenoprotein by cotransfecting
with an SBP2 construct. In each case, SBP2 increased efficiency of
Sec insertion (i.e., the 40-kDa selenoprotein band appeared to be
more enriched). Thus, the new type of SECIS element is not only
functional, but its function could be stimulated by mammalian
SBP2. Moreover, when certain constructs were used, the GGGA
form of SECIS element appeared to be more efficient than the
natural mouse SelH element (e.g., compare lanes 1–4 and 9 and 10,
Fig. 2 B and C).
The New Type of SECIS Element Is Highly Efficient in Sec Insertion.
Another way to monitor efficiency of Sec insertion is to probe
lysates of transfected cells in Western blot assays with anti-GFP
antibodies to determine the ratio between full-length and truncated
forms of the fusion protein (Fig. 2 B Lower and C Lower). The
truncated form is generated by termination of protein synthesis at
the UGA codon because of competition of Sec insertion and
translation termination, whereas the full-length protein is made
whenUGA is read as the Sec codon, and translation continues until
the true stop signal. The ratio of full-length and truncated forms of
fusion proteins that resulted from transfections with various GFP-
SelH chimeras differed in the cell lines used in the study. In HEK
293 cells, the full-length form was predominant, whereas in NIH
3T3 cells, the truncated form was generally more abundant, sug-
gesting lower efficiency of Sec incorporation inNIH3T3 cells under
the conditions used in our study. Quantification of the ratio of
full-length and truncated forms (SI Fig. 10) revealed that the
abundance of the full-length protein expressed from the constructs
carrying Toxoplasma SECIS elements was comparable to that
containing a natural SelH SECIS element. In some cases (e.g.,
Toxoplasma SelT 3UTR construct; see lane 4), the full-length
protein was both the major selenoprotein in HEK 293 cells and
significantly exceeded the corresponding truncated formof protein.
Thus, the GGGA-type of SECIS element not only is functional but
also is extremely efficient in Sec insertion in mammalian cells.
AUGA to GGGA Mutants of Mammalian SECIS Elements of Both Type
I and II Are Functional. To further characterize the GGGA form of
the SECIS element, we testedwhethermammalian SECIS elements
are functional if they contain these structures. In this experiment,
we used GFP-SelS (7) and GFP-SelM (13) constructs, in which we
mutated the natural AUGA forms of SECIS elements to the
GGGA forms (Fig. 3A), and these were transfected into HEK 293
(Fig. 3B) and NIH 3T3 (Fig. 3C) cells. We found the mutant forms
Fig. 1. SECIS elements identified in Toxoplasma and Neospora. (A) Canonical (shown in white background) and the GGGA-type (shown in gray background)
SECIS elements identified in T. gondii and N. caninum are shown. The SECIS core and the unpaired AA nucleotides in the apical loop are shown in bold. (B)
Selenoprotein Q (SelQ). EST sequences (GenBank accession nos. CN615432.1 and CF268978.1) were used for sequence reconstruction. Locations of the initiator
AUG codon, Sec-encoding UGA codon, stop signal, and the SECIS element are indicated.
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were characterized by significantly decreased Sec insertion (com-
pare lanes 1–2 to 3–4 for SelM and lanes 6–7 to 8–9 for SelS). We
also mutated the mouse SelH SECIS to the GGGA form and
transfected cells with this construct (compare lanes 9 and 10 in Fig.
3 B and C to lanes 9 and 10 in Fig. 4 A and B). Again, the mutant
SECIS forms were less efficient in supporting Sec incorporation.
Nevertheless, these structures were functional and stimulated by
SBP2. The mammalian SelM SECIS element may also be viewed
as noncanonical, because it has a CC sequence in the apical bulge
that corresponds to the AA sequence in almost all other eukaryotic
SECIS elements. Finally, SelH on one side and SelS and SelM on
the other represent types I and II SECIS elements, respectively,
which differ by the presence of an additional mini helix (32). It is
clear that both of these SECIS types can use the GGGA form of
SECIS element.
Computational Searches for Canonical and Noncanonical SECIS Ele-
ments in Apicomplexa. Demonstration of the function of the
GGGA-type SECIS elements raised the possibility that such struc-
tures might occur in various organisms, and that they might have
been missed in the previous genomic searches. To address this
possibility, we carried out computational analyses of genomic
sequences for both canonical and noncanonical SECIS elements. In
apicomplexans that contain both AUGA and GGGA forms of
SECIS elements, we identified five selenoproteins in Toxoplasma
gondii and three in N. caninum. SelT, SelW, and SelS-like proteins
occurred in both organisms and corresponded to known seleno-
proteins. SelK was detected only in Toxoplasma. However, the
complete genome is available for T. gondii but not for N. caninum,
which likely has additional selenoprotein genes.
In addition, we identified a previously undescribed selenoprotein
gene, which we designate here as SelQ (Fig. 1B). This protein was
detected in T. gondii, but its homologs were not detected in other
organisms. In the SelQ sequence, Sec was a C-terminal penultimate
residue, and it was followed with a C-terminal cysteine. This Sec
location is similar to that in thioredoxin reductases, SelS and SelK,
but none of these other proteins has a C-terminal cysteine.
GGGA-Type SECIS Elements Are Restricted to Apicomplexa.We tested
whether the GGGA-type SECIS elements occur in nematodes and
Fig. 2. The GGGA form Toxoplasma SECIS element supports Sec insertion in mammalian cells. (A) A scheme illustrating GFP-fusion constructs and cloning strategies
used in the study, as described in detail in Materials andMethods. Predicted sizes of GFP-SelH fusion proteins are displayed at the top. Mouse SelH:Toxoplasma SECIS
chimeras were generated by cloning the corresponding GGGA forms of Toxoplasma sequences immediately downstream of the SelH stop codon (into construct 2 in
the scheme). Distances between stop codons and SECIS elements for WT SelH and Toxoplasma SelT and SelS SECIS elements are shown. Short versions of fusions were
designated as ‘‘SECIS’’ and long as ‘‘3UTR.’’ In B, HEK 293 cells and in C, NIH 3T3 cells were transfected with the constructs shown inA or cotransfected with the SBP2
construct as indicated; lanes 1 and 2 correspond to construct 3 in the scheme inA (GFP-mSelH-Toxoplasma SelT GGGA-type SECIS); lanes 3 and 4 correspond to construct
4 (GFP-mSelH-Toxoplasma SelT GGGA-type 3UTR); lanes 5 and 6 correspond to construct 5 (GFP-mSelH-Toxoplasma SelS GGGA-type SECIS); lanes 7 and 8 correspond
to construct 6 (GFP-mSelH-Toxoplasma SelS GGGA-type 3UTR); lanes 9 and 10 correspond to construct 1 (GFP-mSelH); lane 11 corresponds to construct 2 (GFP-
mSelHSECIS); lane 12 corresponds to GFP-mSelHSecCys; and lane 13 corresponds to GFP (control). Cells were labeled with 75Se. (Upper) Selenoprotein patterns on
SDS/PAGE gels. Migration of major endogenous selenoproteins, thioredoxin reductase 1 (TR1) and glutathione peroxidase 1 (GPx1) is shown on the right. (Lower)
Western blots of the same samples probed with GFP antibodies. The bands corresponding to GFP-SelH fusions are indicated on the left and their sizes on the right.
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mammals. In the nematode searches, we analyzed Caenorhabditis
elegans and Caenorhabditis briggsae genomes (SI Fig. 11). A similar
procedure using theAUGApattern detected a single selenoprotein
gene in these organisms that codes for thioredoxin reductase, but
the GGGA pattern detected no selenoprotein genes. Similarly, the
search of human and mouse genomes identified known selenopro-
tein genes, but SECIS elements of the GGGA-type were not
detected (SI Fig. 12). Finally, we scanned the entireNationalCenter
for Biotechnology Information EST database for GGGA-type
SECIS elements (SI Fig. 13), but this search did not identify
selenoprotein genes besides the Toxoplasma and Neospora seleno-
proteins described above. Thus, it appears that the GGGA-type
SECIS elements are restricted to apicomplexa.
The GGGA-Type Toxoplasma SECIS Element Is Highly Efficient. As
discussed above, the Toxoplasma SelT and SelS SECIS elements
were found to be highly efficient in Sec insertion in mammalian
cells; in addition, comparison of AUGA and GGGA forms of
mammalian SECIS elements revealed that the AUGA forms were
more efficient. Thus, we hypothesized that the AUGA form of the
Toxoplasma SelT and SelS elements could be even more efficient
in Sec insertion. To functionally characterize such forms of Toxo-
plasma SelT and SelS SECIS elements, we transfected HEK 293
(Fig. 4A) and NIH 3T3 (Fig. 4B) cells with various GFP-SelH
constructs and metabolically labeled these cells with 75Se. The
expected 40-kDa selenoprotein band was detected (lanes 1–10, Fig.
4 A Upper and B Upper). Once again, for all constructs, cotrans-
Fig. 3. GGGA mutant forms of mammalian SECIS elements are functional. (A)
Mammalian SECIS elements used in the study that represent three known
types of eukaryotic SECIS elements. Mutations made in the structures are
indicated. In B, HEK 293 cells and in C, NIH 3T3 cells were transfected with the
following constructs: lane 1, GFP-mSelM (WT); lane 2, GFP-mSelM (WT) 
SBP2; lane 3, GFP-SelM ATGG SECIS mutant; lane 4, GFP-SelM ATGG SECIS
mutant  SBP2; lane 5, GFP (control); lane 6, GFP-mSelS (WT); lane 7, GFP-
mSelS (WT) SBP2; lane 8, GFP-mSelS ATGG SECIS mutant; lane 9, GFP-mSelS
ATGG SECIS mutant  SBP2; and lane 10, GFP (control). Cells were labeled
with 75Se. Migration of proteins expressed from the constructs and major
endogenous selenoproteins are indicated.
Fig. 4. The ATGA form of the GGGA-type Toxoplasma SECIS element is highly
efficient in Sec insertion. In A, HEK 293 cells and in B, NIH 3T3 cells were
transfected with the following constructs: lane 1, GFP-mSelH-Toxoplasma SelT
GGAT SECIS mutant; lane 2, GFP-mSelH-Toxoplasma SelT GGAT SECIS mutant
 SBP2; lane 3, GFP-mSelH-Toxoplasma SelT GGAT 3UTR mutant; lane 4,
GFP-mSelH-Toxoplasma SelT GGAT 3UTR mutant SBP2; lane 5, GFP-mSelH-
Toxoplasma SelS GGAT SECIS mutant; lane 6, GFP-mSelH-Toxoplasma SelS
GGAT SECIS mutant SBP2; lane 7, GFP-mSelH-Toxoplasma SelS GGAT 3UTR
mutant; lane 8, GFP-mSelH-Toxoplasma SelS GGAT 3UTR mutant SBP2; lane
9, GFP-mSelH (WT); lane 10, GFP-mSelH (WT) SBP2; lane 11, GFP-mSelHSECIS;
lane 12, GFP-mSelH SecCys; and lane 13, GFP (control).Upper represent seleno-
protein patterns based on metabolic labeling of cells with 75Se. Lower shows
Western blots developed with anti-GFP antibodies.
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fection with SBP2 increased Sec insertion (analyzed by abundance
of the 75Se-labeled form and the ratio of full-length and truncated
forms; Fig. 4ALower andBLower). Quantification of the bands (SI
Fig. 14) revealed that the most efficient Sec insertion occurred in
the case of the construct containing the GGGA to ATGA mutant
of Toxoplasma SelT SECIS element (lanes 1–4, Fig. 4 A and B).
Development of a Vector for Overexpression of Selenoproteins in
Mammalian Cells. Expression of Sec-containing proteins in mam-
malian cells, especially at high levels, is challenging. We took
advantage of the efficient Sec insertion by the ATGA form of the
Toxoplasma SelT SECIS element, as well as of the dependence of
this process on SPB2, to develop a vector for overexpression of
selenoproteins in mammalian cells. For this purpose, we used
pBudCE4.1 vector, designed for simultaneous expression of two
genes. This vector contains the human CMV immediate-early
promoter and the human elongation factor 1-subunit (EF-1)
promoter for high level, constitutive expression of recombinant
proteins.We cloned aC-terminal functional domain of rat SBP2 for
expression under the EF-1 promoter and the AUGA form of
Toxoplasma SelT SECIS element into the second cloning site for
expression of a selenoprotein under the CMV promoter (Fig. 5A).
The resulting expression vector was designated as pSelExpress1. To
test this vector for selenoprotein expression, we cloned the mouse
GPx1 ORF containing an N-terminal His-tag into pSelExpress1
and separately into the corresponding vector lacking the SBP2 gene.
HEK 293 cells were transfected with these constructs and the cells
labeled with 75Se.We further enriched the recombinant GPx1 from
the transfected cells on an affinity column. The abundance of the
24-kDaGPx1 band increased in the order GPx1-pBud-Toxoplasma
SECISGPx1-pBud-Toxoplasma SECIS SBP2GPx1-pSelEx-
press1.We also probed the samples with anti-GPx1 antibodies (Fig.
5B Middle), which showed a similar pattern. Because GPx1 is a
homotetramer, the native GPx1 form copurified with that ex-
pressed from pSelExpress1.
Selenoproteins are notoriously difficult targets for recombinant
expression. The bacterial Sec insertion system is different from that
in eukaryotes, in that the bacterial SECIS is present in the coding
region downstream of the Sec codon, whereas the eukaryotic
SECIS is in the 3-UTR. Therefore, expression of recombinant
proteins in E. coli requires modification of the coding regions of
selenoproteins in the vicinity of their active sites. In addition,
efficiency of Sec insertion into recombinant proteins is low, because
themajor products are often the truncated forms of selenoproteins.
To overcome this problem, several methods have been proposed
(33–36), but none is fully satisfactory. Furthermore, some seleno-
proteins can be expressed only in eukaryotes because of unique
posttranslational modifications. However, the major problem re-
mains the low yield and high cost of recombinant selenoprotein
expression. Therefore, the development of the vector for seleno-
protein overexpression in mammalian cells has an important prac-
tical outcome, and the use of this vector may stimulate research in
molecular biology and biochemistry of selenoproteins.
In conclusion, we identified a noncanonical form of eukaryotic
SECIS element and a previously undescribed selenoprotein, SelQ.
The SECIS does not conserve the nucleotide previously considered
invariant in the SBP2 binding site, yet it is fully functional. This
SECIS was detected in only two aplicomplexan parasites, Toxo-
plasma andNeospora, but it supports Sec insertion inmammals.We
used the new SECIS form to develop a tool for efficient expression
of recombinant selenoproteins in mammalian cells.
Materials and Methods
Search for Canonical Toxoplasma SECIS Elements. A stand-alone
version of SECISearch with the default pattern was used (7). The
search procedure included: (i) Analysis of primary nucleotide
sequence and secondary structures. We used PatScan to search the
target database for the candidates satisfying the NUGAAAGA
Fig. 5. Vector for high expression of selenoproteins in mammalian cells. (A)
Vector map of pSelExpress1. The GGGAATGA mutant of Toxoplasma SelT
SECIS element is preceded by a multiple cloning site (MCS) and by the human
CMV immediate-early promoter. The C-terminal portion of rat SBP2 is under
the control of the human elongation factor 1-subunit promoter. Other major
features of the vector backbone are indicated. (B) Expression and enrichment
of recombinant His-tagged GPx1 on metal-affinity resin. HEK 293 cells were
transfected with GPx1-pBudCE4.1 (lane 1), GPx1-pBudCE4.1 cotransfected
with SBP2 (lane 3), and GPx1-pSelExpress1 (lane 5) or with pBudCE4.1 as
control (lane 7). Cell lysates were prepared as described in Materials and
Methods, and GPx1 was enriched from each sample on TALON resin. Proteins
bound to the resin were loaded in lanes 2, 4, 6, and 8, as shown. Top shows
metabolic labeling of cells with 75Se; Middle, Western blot with anti-GPx1
antibodies; and Bottom, protein staining with Amido Black. Because GPx1 is a
tetramer, the His-tagged GPx1 expressed from pSelExpress1 binds the endog-
enous GPx1 (21-kDa band), which is then also enriched on TALON resin (see
lower bands in lanes 2, 4, and 6, but not in 8).
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pattern. (ii) Estimation of the free energy. RNAfold from the
Vienna RNA package (www.tbi.univie.ac.at/ivo/RNA) was used
to calculate the free energies for whole structures and separately for
their upper stem-loops. The threshold value was12.6 kcal/mol for
the whole structure and3.7 kcal/mol for the upper stem-loop. (iii)
Protein identification (analysis of location of SECIS elements and
identification of ORFs). Candidate structures located on the com-
plementary strand were filtered out. (iv) ORF analysis. This final
step consisted of sequence analyses of predicted ORFs and iden-
tification of candidate Sec-encoding UGA codons.
Search for Noncanonical Toxoplasma SECIS Elements. The search for
noncanonical SECIS elements was carried out as described above
for canonical SECIS elements, except that NTGA was replaced by
NGGA in the primary sequence. Although no noncanonical SECIS
elements other than the GGGA-type structures were discovered by
homology searches involving known selenoproteins, the search
settings were relaxed to allow any nucleotide preceding GGA (or
UGA) for better sensitivity.
Cloning Strategies. GFP-fusion constructs developed and used in
the study are shown in the scheme in Fig. 2A. SelH cDNA
containing the in-frame TGA codon but lacking the entire 3UTR
was amplified and cloned into pEFGP-C3 (Clontech, Mountain
View, CA), and all subsequent constructs containing Toxoplasma
SECIS elements were developed by using this GFP-SelH3UTR
fusion construct (Fig. 2A, construct 2). Toxoplasma SelT and SelS
SECIS elements (130-bp region, constructs 3 and 5, respectively) or
the sequences beginning with the corresponding stop codons and
containing SECIS elements (300-bp region, constructs 4 and 6)
were amplified and cloned immediately downstream of the SelH
stop codon. The rationale was as follows: the SelH SECIS is located
very close to the stop codon (construct 1). Therefore, the constructs
having the 130-bp sequences of Toxoplasma SECIS elements were
regarded as corresponding to substitution of themammalian SECIS
element with the Toxoplasma structures, whereas the constructs
containing the 300-bp sequences of Toxoplasma SelT 3UTRor the
350-bp sequence of Toxoplasma SelS 3UTRs were substitutions
that introduced the corresponding 3UTRs. We further mutated
the GG bases in the SECIS quartet in both Toxoplasma SelT and
SelS to AT (i.e., ToxoplasmaGG toATmutants). Likewise, the AT
bases in GFP-mSelHwt, GFP-mSelSwt, and GFP-mSelMwt (Fig.
4A) fusions were mutated to the GG (i.e., mouse AT to GG
mutants) by using theQuikChangemutagenesis kit (Stratagene, La
Jolla, CA).
The vector for expression of selenoproteins in mammalian
cells was developed on the basis of pBudCE4.1 (Invitrogen,
Carlsbad, CA). First, the C-terminal domain of rat SBP2 was
cloned into the first cloning site for expression under the EF1
promoter. Subsequently, the Toxoplasma SelT ATGG SECIS
was cloned into the second multiple cloning site. Finally, mouse
GPx1 sequence containing an in-frame TGA codon, but lacking
a 3UTR, was amplified and cloned into the vector. As a control,
we used the construct wherein mGPx1-Toxoplasma SelT SECIS
ATGG mutant was cloned into pBudCE4.1 that did not have
the rat SBP2 sequence. To quantify the ratio of full-length and
truncated forms, we used Scion Image 4.0 (Scion, Frederick,
MD) for image processing and analysis.
Cell Culture, Transfection, and Metabolic Labeling. Mouse NIH 3T3
and human HEK 293 cells were cultured in DMEM supplemented
with 10% FBS, 100 units/ml penicillin, and 100 units/ml strepto-
mycin. Cells were seeded in six-well plates and transfected as
follows: NIH 3T3 cells using Lipofectamin and Plus reagent (In-
vitrogen) according to the manufacturer’s protocol and HEK 293
using the calcium-phosphate method in OPTI-MEM (Invitrogen),
or cotransfected in a ratio of 2:1 with the rat SBP2 expression
construct that was the generous gift of Paul Copeland and Donna
Driscoll, Cleveland Clinic Foundation, Cleveland, OH. In 12–24 h
after transfection, the medium was replaced with DMEM supple-
mented with 75Se (specific activity 1,000 Ci/mmol; 1 Ci	 37 GBq),
and the cells were incubated for an additional 12–24 h.
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